Ortho-Clinical Diagnostics, Inc

Other

Janssen Diagnostics, LLC

John W Backus

Yi Zhang

Jian Zheng

Thomas J Cummins

Carol A Kreader

Susan Melissa Atwood

Tatiana Vener

Yixin Wang

George Bashirians

Fei Yang

Timothy Jatkoe

Carol Kreader

Ann E Casey

Eric B Rasmussen

Rashmi Mehta

Joanne H Kerschner

Gregory M Preston

Jack X Yu

Dondapati Chowdary

Abhijit Mazumder

Dongho Lee

Dong-Ho Lee

Disclosed herein are compositions and methods comprising two or more proteins in which at least one of the proteins has been altered to reduce their mutual recognition and binding. Such compositions are useful as reference, calibrators or controls in methods and assays for determining the amount of one or more of the proteins that may be present in a sample of interest or in confirming the presence of one or more of the proteins in the sample. More particularly, it relates to compositions and methods comprising altered placental growth factor-1 (PlGF-1) and soluble fms-like tyrosine kinase (sFlt-1) and methods for determining the amount or confirming the presence of sFlt-1 and/or PlGF-1 in a sample of interest.

Calibrator/control for simultaneous assay of proteins capable of complexing with one another

Reference, calibrator, or control composition of PIGF-1 and sFlt-1

The present invention relates to methods for separating nucleic acids from other cellular debris, especially substances that carry a net positive charge at low pH, by electrophoresis under acid conditions. In the purification method of the present invention, nucleic acids are separated from proteins found in the same biological sample by applying the sample to an electrophesis gel and subjecting the sample to electrophoresis under acid conditions to separate the nucleic acids from the proteins. The optimum pH may differ for different sample types but can be readily determined by those skilled in the art. Preferably, the separation is performed at a pH of about 2 to about 4. More preferably, electrophoresis is carried out at a pH of 2.5

Electrophoretic separation of nucleic acids from proteins at low ph

Disclosed herein are improved methods for amplifying nucleic acids. The methods encompass a method for increasing the specificity of amplification of a target nucleic acid in an amplification reaction, where the reaction reagents include one or more oligonucleotide amplification primers specific to the target nucleic acid, a target nucleic acid, a nucleic acid polymerase, and one or more magnesium salts, by preparing a primer/carrier mixture comprising one or more oligonucleotide amplification primers and carrier nucleic acid, and contacting the primer/carrier admixture with target nucleic acid, one or more magnesium salts, and nucleic acid polymerase.

Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid

The present invention relates to methods for concentrating bacteria from a viscous biological sample. The methods involve adding to the sample a water-soluble, density-lowering agent having a density of 0.7 to 0.9 g/ml and a boiling point greater than 50.degree. C. The invention also relates to methods for concentrating bacteria and free bacterial nucleic acids from a biological sample that involve mixing with the sample a density-lowering agent and a monovalent salt.

Use of an alcohol-salt buffer wash for the efficient recovery of

The present invention relates to methods and test kits for the amplification and detection of nucleic acids from human immunodeficiency virus (HIV) type 1 and/or type 2. The methods use multiple primer sets to amplify all subtypes of HIV-1, including group M and group O isolates, and all subtypes of HIV-2.

Amplification and detection of HIV-1 and/or HIV 2

Growing community of inventors

Ontario, NY, United States of America

John W Backus